A Silicon Valley start-up is making cancer treatment for dogs more precise

  • 📰 CNBC
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 72%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Silicon Valley start-up One Health says it's too soon to publish data, but says many of its canine clients are living longer than would be expected using traditional treatment.

One Health is using its FidoCure product to bring precision medicine to canine cancer care.

"I was heartbroken," said Guptill, who adopted Lulu when the dog was 8 weeks old. "She's just like a member of the family." Much like people, dogs with cancer are treated with some combination of surgery, chemotherapy and radiation. But unlike for humans, there is only one targeted cancer therapy available for dogs: Palladia, made byThe market for pet cancer therapeutics is growing at 10.8% annually, and will increase from $178 million in 2018 to $300 million by 2024, according to Global Market Insights.

Lopes said, "There is a spirit of the intention of it being a bit safer, gentler and more efficacious. Of course, it's still cancer therapy, not Advil." In fact, Dr. Sabhlok said the FidoCure results prompted her to use a different protocol than she otherwise would have, after the gene mapping showed one of the drugs would not have worked on Lulu's cancer.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in HEALTH

Health Health Latest News, Health Health Headlines